13.96 -0.63 (-4.33%)
PFWD
Stock Details
Last Trade:13.96 Change:-0.63 (-4.33%) Prev Close:14.59 Open: 14.55 Days Range:13.92 – 14.77 52 Week Range: 9.01 - 22.99 Volume:479576 P/E: 43.63EPS:0.32
View AllRecent Alerts 07/04/09
Recent Alert on 07/01/09 at 7:25am
Piper Jaffray Downgrades Phase Forward (PFWD) to Neutral; Lack of Near-Term Catalysts
Piper Jaffray Downgrades Phase Forward (PFWD) to Neutral; Lack of Near-Term Catalysts
Piper Jaffray & Co. downgrades Phase Forward (Nasdaq: PFWD) from Buy to Neutral. Piper analyst says, "GlaxoSmithKline (NYSE: GSK) signed a multi-year renewal agreement for PhaseForward's InForm Electronic Data Capture System. GSK is PFWD's... Read More
Recent Alert on 06/30/09 at 1:43pm
Phase Forward (PFWD) Signs Multi-Yr, Multi-Million Dollar Contract with GlaxoSmithKline (GSK)
Phase Forward (PFWD) Signs Multi-Yr, Multi-Million Dollar Contract with GlaxoSmithKline (GSK)
Recent Alert on 06/25/09 at 11:03am
Leerink Swann Resumed Healthcare Technology and Distribution Sector With Positive Bias
Leerink Swann Resumed Healthcare Technology and Distribution Sector With Positive Bias
Recent Alert on 04/29/09 at 9:43am
Morning Movers 4/29: DNDN, DWA, MSPD, PFWD, PSYS Higher; ETFC, BCRX, ROC, BLDP, SSYS Lower
Morning Movers 4/29: DNDN, DWA, MSPD, PFWD, PSYS Higher; ETFC, BCRX, ROC, BLDP, SSYS Lower
View AllRecent Press Releases
Press Release on 06/30/09 at 1:38pm
Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements
Phase Forward Customer GlaxoSmithKline Signs Multi-Year Agreements
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 03/19/09 at 11:40am
Analyst upgrades, downgrades and initiations: AA, NOK, EXPE, MTB, CSC ...
Analyst upgrades, downgrades and initiations: AA, NOK, EXPE, MTB, CSC ...